These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

333 related items for PubMed ID: 21099453

  • 1. Posterior vitreous detachment with microplasmin alters the retinal penetration of intravitreal bevacizumab (Avastin) in rabbit eyes.
    Goldenberg DT, Giblin FJ, Cheng M, Chintala SK, Trese MT, Drenser KA, Ruby AJ.
    Retina; 2011 Feb; 31(2):393-400. PubMed ID: 21099453
    [Abstract] [Full Text] [Related]

  • 2. Electrophysiologic and retinal penetration studies following intravitreal injection of bevacizumab (Avastin).
    Shahar J, Avery RL, Heilweil G, Barak A, Zemel E, Lewis GP, Johnson PT, Fisher SK, Perlman I, Loewenstein A.
    Retina; 2006 Mar; 26(3):262-9. PubMed ID: 16508424
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Vitreomacular Interface after Anti-Vascular Endothelial Growth Factor Injections in Neovascular Age-Related Macular Degeneration.
    Veloso CE, Kanadani TM, Pereira FB, Nehemy MB.
    Ophthalmology; 2015 Aug; 122(8):1569-72. PubMed ID: 26038338
    [Abstract] [Full Text] [Related]

  • 6. Penetration of bevacizumab through the retina after intravitreal injection in the monkey.
    Heiduschka P, Fietz H, Hofmeister S, Schultheiss S, Mack AF, Peters S, Ziemssen F, Niggemann B, Julien S, Bartz-Schmidt KU, Schraermeyer U, Tübingen Bevacizumab Study Group.
    Invest Ophthalmol Vis Sci; 2007 Jun; 48(6):2814-23. PubMed ID: 17525217
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Vitrectomy after intravitreal bevacizumab (Avastin) for retinal detachment in retinopathy of prematurity.
    Kychenthal A, Dorta P.
    Retina; 2010 Apr; 30(4 Suppl):S32-6. PubMed ID: 20224474
    [Abstract] [Full Text] [Related]

  • 12. Pharmacokinetics of intravitreal bevacizumab (Avastin).
    Bakri SJ, Snyder MR, Reid JM, Pulido JS, Singh RJ.
    Ophthalmology; 2007 May; 114(5):855-9. PubMed ID: 17467524
    [Abstract] [Full Text] [Related]

  • 13. Posterior vitreous detachment following intravitreal drug injection.
    Geck U, Pustolla N, Baraki H, Atili A, Feltgen N, Hoerauf H.
    Graefes Arch Clin Exp Ophthalmol; 2013 Jul; 251(7):1691-5. PubMed ID: 23381655
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Pharmacokinetics of intravitreal ranibizumab (Lucentis).
    Bakri SJ, Snyder MR, Reid JM, Pulido JS, Ezzat MK, Singh RJ.
    Ophthalmology; 2007 Dec; 114(12):2179-82. PubMed ID: 18054637
    [Abstract] [Full Text] [Related]

  • 19. Effect of intravitreal bevacizumab (avastin) on the growing rabbit eye.
    Axer-Siegel R, Herscovici Z, Hasanreisoglu M, Kremer I, Benjamini Y, Snir M.
    Curr Eye Res; 2009 Aug; 34(8):660-5. PubMed ID: 19899993
    [Abstract] [Full Text] [Related]

  • 20. Microplasmin degrades fibronectin and laminin at vitreoretinal interface and outer retina during enzymatic vitrectomy.
    Chen W, Mo W, Sun K, Huang X, Zhang YL, Song HY.
    Curr Eye Res; 2009 Dec; 34(12):1057-64. PubMed ID: 19958125
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.